MALLINCKRODT INC FDA Approval ANDA 087845

ANDA 087845

MALLINCKRODT INC

FDA Drug Application

Application #087845

Application Sponsors

ANDA 087845MALLINCKRODT INC

Marketing Status

Prescription001

Application Products

001TABLET;ORAL25MG0TOFRANILIMIPRAMINE HYDROCHLORIDE

FDA Submissions

ORIG1AP1984-05-22
LABELING; LabelingSUPPL9AP1993-02-02
LABELING; LabelingSUPPL12AP1994-12-20
LABELING; LabelingSUPPL14AP1998-09-01
LABELING; LabelingSUPPL20AP2004-08-31
LABELING; LabelingSUPPL21AP2005-06-09
LABELING; LabelingSUPPL22AP2005-09-12
LABELING; LabelingSUPPL24AP2007-06-25
LABELING; LabelingSUPPL25AP2007-09-27
LABELING; LabelingSUPPL27AP2014-07-17STANDARD
LABELING; LabelingSUPPL28AP2017-06-29STANDARD

Submissions Property Types

SUPPL27Null15
SUPPL28Null15

TE Codes

001PrescriptionAB

CDER Filings

MALLINCKRODT INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 87845
            [companyName] => MALLINCKRODT INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"TOFRANIL","activeIngredients":"IMIPRAMINE HYDROCHLORIDE","strength":"25MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"TOFRANIL","submission":"IMIPRAMINE HYDROCHLORIDE","actionType":"25MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.